Drug Type Small molecule drug |
Synonyms TQA 3810, TQA-3810, TQA3810 |
Target |
Action agonists |
Mechanism TLR8 agonists(Toll like receptor 8 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 2 | China | 13 Mar 2024 |
Phase 1 | 90 | uzeacsrfkc(akorfsekdn) = rtoedonbmo zlmxbjsogu (agvwwppaba ) View more | Positive | 15 Nov 2024 | |||
uzeacsrfkc(akorfsekdn) = fsuhocbvqp zlmxbjsogu (agvwwppaba ) View more |





